Prospective comparison of subcutaneous vs intravenous administration of bortezomib in patients with multiple myeloma: Pharmacokinetics, efficacy and

被引：0
作者：
Moreau, P.
Coiteux, V.
Hulin, C.
Facon, T.
van de Velde, H.
Acharya, M.
Harousseau, J. L.
机构：
[1] Univ Hosp Nantes, Dept Hematol, Nantes, France
[2] Johnson & Johnson Pharmaceut R&D, Beerse, Belgium
[3] Johnson & Johnson Pharmaceut R&D, Raritan, NJ USA
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：158 / 158
页数：1
相关论文
共 50 条
  • [31] Intravenous (IV) bortezomib infusion after non-response to subcutaneous bortezomib administration can induce transitory responses in multiple myeloma patients: are some patients more sensitive to IV bortezomib?
    Gozzetti, Alessandro
    Candi, Veronica
    Brambilla, Corrado Zuanelli
    Papini, Giulia
    Bocchia, Monica
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 177 (01) : 144 - 147
  • [32] Subcutaneous Administration of Bortezomib in Combination with Thalidomide and Dexamethasone for Treatment of Newly Diagnosed Multiple Myeloma Patients
    Wu, Shenghao
    Zheng, Cuiping
    Chen, Songyan
    Cai, Xiaoping
    Shi, Yuejian
    Lin, Bijing
    Chen, Yuemiao
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [33] EFFICACY AND SAFETY OF THREE SUBCUTANEOUS BORTEZOMIB COMBINATIONS IN ELDERLY, NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS
    Cerrato, C.
    Oliva, S.
    Petrucci, M. T.
    Caraffa, P.
    Nozzoli, C.
    Finsinger, P.
    Larocca, A.
    De Rosa, L.
    De Paoli, L.
    Montefusco, V.
    Saraci, E.
    Villani, O.
    Carella, A. M.
    Benevolo, G.
    Morabito, F.
    Liberati, A. M.
    Derudas, D.
    Boccadoro, M.
    Sonneveld, P.
    Palumbo, A.
    HAEMATOLOGICA, 2014, 99 : 107 - 107
  • [34] SUBCUTANEOUS BORTEZOMIB IN PATIENTS OVER 75 YEARS WITH MULTIPLE MYELOMA
    Violeta, Martinez-Robles
    Belen, Ballina
    Seila, Cerda
    Filomeno, Rondon
    Natalia, De Las Heras
    Jose-Antonio, Rodriguez-Garcia
    Fernando, Escalante
    HAEMATOLOGICA, 2016, 101 : 302 - 302
  • [35] Pharmacokinetics of Trastuzumab After Subcutaneous and Intravenous Administration in Obese Patients
    Gonzalez Garcia, Jonathan
    Gutierrez Nicolas, Fernando
    Ramos Diaz, Ruth
    Nazco Casariego, Gloria Julia
    Vina Romero, Maria Micaela
    Llabres Martinez, Matias
    Llanos Munoz, Marta
    Batista Lopez, Jose Norberto
    Jimenez Sosa, Alejandro
    Ceballos Lenza, Isaac
    Cruz Jurado, Josefina
    ANNALS OF PHARMACOTHERAPY, 2020, 54 (08) : 775 - 779
  • [36] IRON ADMINISTRATION INCREASES BORTEZOMIB EFFICACY IN MULTIPLE MYELOMA MURINE MODELS
    Bordini, Jessica
    Morisi, Federica
    Fulli, Alessia
    Venturi, Gianluca
    Camaschella, Clara
    Campanella, Alessandro
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (08) : E398 - E398
  • [37] Clinical Risk Factors for Peripheral Neuropathy in Patients Treated with Subcutaneous or Intravenous Bortezomib for Newly Diagnosed Multiple Myeloma
    Merz, Maximillan
    Salwender, Hans-Juergen
    Haenel, Mathias
    Bertsch, Uta
    Kunz, Christina
    Hielscher, Thomas
    Blau, Igor W.
    Scheid, Christof
    Mai, Elias Karl
    Hose, Dirk
    Schurich, Baerbel
    Munder, Markus
    Brossart, Peter
    Gerecke, Christian
    Lindemann, Hans Walter
    Zeis, Matthias
    Weisel, Katja C.
    Duerig, Jan
    Goldschmidt, Hartmut
    BLOOD, 2015, 126 (23)
  • [38] Comparison of the pharmacokinetics of subcutaneous and intravenous administration of a phosphorothioate oligodeoxynucleotide in cynomolgus monkeys
    Leeds, JM
    Henry, SP
    Geary, R
    Burckin, T
    Levin, AA
    ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 2000, 10 (06): : 435 - 441
  • [39] Pharmacokinetics and pharmacodynamics comparison between subcutaneous and intravenous butorphanol administration in horses
    Chiavaccini, L.
    Claude, A. K.
    Lee, J. H.
    Ross, M. K.
    Meyer, R. E.
    Langston, V. C.
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2015, 38 (04) : 365 - 374
  • [40] Clinical Administration Characteristics of Subcutaneous and Intravenous Administration of Daratumumab in Patients With Multiple Myeloma at Mayo Clinic Infusion Centers
    Soefje, Scott A.
    Carpenter, Corinne
    Carlson, Katherine
    Awasthi, Samir
    Lin, Thomas S.
    Kaila, Shuchita
    Tarjan, Daniel
    Kayal, Nikhil
    Kirkup, Christian
    Wagner, Tyler E.
    Gray, Kathleen S.
    Kumar, Shaji
    JCO ONCOLOGY PRACTICE, 2023, 19 (04) : 208 - +
12345